Bamco Inc Moderna, Inc. Transaction History

Bamco Inc

$36.8 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $29.2 Million - $43.8 Million	-419,369 Reduced 98.24%	7,500 $745,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $40.3 Million - $53 Million	418,269 Added 4863.59%	426,869 $44.1 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $580,650 - $786,597	-4,900 Reduced 36.3%	8,600 $1.04 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $2.24 Million - $3.25 Million	-16,500 Reduced 55.0%	13,500 $2.07 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $1.54 Million - $2.73 Million	13,000 Added 76.47%	30,000 $5.39 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $625,771 - $1.03 Million	5,300 Added 45.3%	17,000 $2.01 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $1.37 Million - $2.07 Million	11,700 New	11,700 $1.67 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $320,196 - $595,146	-2,532 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $10.6 Million - $17.2 Million	-46,800 Reduced 94.87%	2,532 $643,000
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $3.54 Million - $7.73 Million	-15,950 Reduced 24.43%	49,332 $19 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $2.74 Million - $4.96 Million	21,100 Added 47.76%	65,282 $15.3 Million
Q1 2021 May 19, 2021	BUY	$109.18 - $185.98 $4.41 Million - $7.51 Million	40,382 Added 1062.68%	44,182 $5.79 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $249,811 - $645,468	3,800 New	3,800 $397,000
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $54,340 - $94,850	-1,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $29,670 - $80,000	1,000 New	1,000 $64,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account